Perioperative adjuvant chemotherapy vs postoperative chemotherapy for one year
✍ Scribed by Roar Nissen-Meyer; Herman Høst; Kjell Kjellgren; Bror Månsson; Torsten Norin
- Publisher
- Springer US
- Year
- 1982
- Tongue
- English
- Weight
- 341 KB
- Volume
- 2
- Category
- Article
- ISSN
- 0167-6806
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Since June 1978, 57 patients with primary osteogenic sarcoma of an extremity were treated with highdose methotrexate (HDMTX) and citrovorum factor rescue (CFR), Adriamycin, and the combination of bleomycin, cyclophosphamide and dactinomycin (BCD) given for 4-16 weeks prior to definitive surgery. His
Thirty-eight patients with node positive squamous cell carcinoma of the esophagus were entered into a pilot clinical study using postoperative adjuvant chemotherapy (cisplatinum 100 mg/m2 and methotrexate 150 mg/m2 X 4 cycles) with an intent of improving cure rates and overall survival. Patient comp